Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Pulsed electric field treatment may help shrink untreated liver tumors.

A new treatment effectively kills antibiotic-resistant bacteria and helps wounds heal faster by boosting the immune response.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.